nexos_logo-full.jpg

Novel therapeutics for inflammation diseases by using exosomes as delivery vehicles for advanced drugs

All cells in the human body release nano-sized extracellular vesicles (EV) that contribute cell-to-cell communications by delivery of many proteins, lipids and gene materials. Nexocure plan to develop novel therapeutics for dry eye disease by deploying technologies from EV as a first indication

GUV Contact: Helena Lundquist

  • back to portfolio